A Study of Elaprase in Children and Adults With Hunter Syndrome (Mucopolysaccharidosis II) in India
Clinical trial NCT05058391 · COMPLETED
Trial details
- NCT number
- NCT05058391
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-21
- Primary completion
- 2024-04-06
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.